Rapid Micro Biosystems Inc (RPID)
1.12
-0.06
(-5.08%)
USD |
NASDAQ |
Nov 14, 12:27
Rapid Micro Biosystems Total Liabilities (Quarterly): 21.47M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.47M |
| June 30, 2024 | 22.50M |
| March 31, 2024 | 21.79M |
| December 31, 2023 | 25.46M |
| September 30, 2023 | 22.38M |
| June 30, 2023 | 21.32M |
| March 31, 2023 | 20.84M |
| December 31, 2022 | 26.48M |
| Date | Value |
|---|---|
| September 30, 2022 | 22.90M |
| June 30, 2022 | 21.18M |
| March 31, 2022 | 22.98M |
| December 31, 2021 | 20.19M |
| September 30, 2021 | 19.68M |
| June 30, 2021 | 57.93M |
| March 31, 2021 | 56.13M |
| December 31, 2020 | 45.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.68M
Minimum
Sep 2021
57.93M
Maximum
Jun 2021
28.02M
Average
22.44M
Median
Total Liabilities (Quarterly) Benchmarks
| Standard BioTools Inc | 192.21M |
| Ainos Inc | 14.83M |
| Zomedica Corp | 11.16M |
| LENSAR Inc | 37.76M |
| Intelligent Bio Solutions Inc | 5.596M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 105.84M |
| Shareholders Equity (Quarterly) | 84.37M |
| Current Ratio | 5.524 |